Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/08/2012 | US20120282301 Porous calcium phosphate bone material |
11/08/2012 | US20120282300 Protein biomaterials and biocoacervates and methods of making and using thereof |
11/08/2012 | US20120282299 Coatings comprising bis-(alpha-amino-diol-diester) containing polyesteramide |
11/08/2012 | US20120282298 Corticosteroids for the treatment of joint pain |
11/08/2012 | US20120282297 Method for treating constipation |
11/08/2012 | US20120282270 Formulation of human antibodies for treating tnf-alpha associated disorders |
11/08/2012 | US20120282242 Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
11/08/2012 | US20120282191 Orally dispersible tablet |
11/08/2012 | US20120282190 Compositions, methods, and kits comprising a dry shampoo composition |
11/08/2012 | US20120282189 Improved Medicinal Aerosol Formulations |
11/08/2012 | US20120282187 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy |
11/08/2012 | US20120282186 Templated nanoconjugates |
11/08/2012 | US20120282182 Nanoparticle clusters formed from individual nanoparticles of two or more types |
11/08/2012 | US20120282176 Method and Constructs for the pH Dependent Passage of the Blood-brain-barrier |
11/08/2012 | US20120282172 Targeted delivery to human diseases and disorders |
11/08/2012 | US20120279881 Implantable medical devices comprising bio-degradable alloys |
11/08/2012 | DE102011075354A1 Dosage form comprises at least one first active substance-containing unit, and at least one second active substance-containing unit, and both units comprise a first active substance |
11/08/2012 | CA2839790A1 Rapid dissolve tablet compositions for vaginal administration |
11/08/2012 | CA2834900A1 Formulation for anti-.alpha.4.beta.7 antibody |
11/08/2012 | CA2834885A1 Composition and method for treatment of diabetes |
11/08/2012 | CA2834788A1 Cochleate compositions and methods of making and using same |
11/08/2012 | CA2831572A1 Ultrafiltration concentration of allotype selected antibodies for small-volume administration |
11/08/2012 | CA2831340A1 Excipient compatibility with ezatiostat |
11/07/2012 | EP2520312A1 A process for manufacturing a delivery system for active components as part of an edible composition |
11/07/2012 | EP2520305A1 Medicinal composition including sunflower extract, preparative method and use thereof |
11/07/2012 | EP2520303A1 Anti-wart pharmaceutical composition |
11/07/2012 | EP2520301A2 Parenteral pharmaceutical formulation in suspension, having sustained release, in low and ultralow dosage, in hormonal therapy in the climacteric syndrome |
11/07/2012 | EP2520300A1 Pharmaceutical composition for oral administration |
11/07/2012 | EP2520299A1 Solid pharmaceutical composition for oral administration |
11/07/2012 | EP2520296A1 New association between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it. |
11/07/2012 | EP2520289A1 Norethisterone-containing patch |
11/07/2012 | EP2520288A1 Production method of solid preparation and the preparation produced by the method |
11/07/2012 | EP2520287A1 Loading of hydrophobic drugs into hydrophilic polymer delivery systems |
11/07/2012 | EP2520286A1 Pharmaceutical compositions of rhein or diacerein |
11/07/2012 | EP2520285A1 Pharmaceutical compositions of rhein or diacerein |
11/07/2012 | EP2520284A1 Pharmaceutical compositions of rhein or diacerein |
11/07/2012 | EP2520283A1 Pharmaceutical compositions of rhein or diacerein |
11/07/2012 | EP2520282A2 Vials of vancomycin vhloridrate with improved stability |
11/07/2012 | EP2520281A2 Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof |
11/07/2012 | EP2520280A2 Water-swellable polymer with misoprostol |
11/07/2012 | EP2520279A1 Thermoreversible gel pharamaceutical compositions for odontoiatric use |
11/07/2012 | EP2520257A1 Adhesive tape preparation |
11/07/2012 | EP2520183A1 Use of agents containing Hydroxystilbene for preventing and/or treating illnesses |
11/07/2012 | EP2519264A1 Taste masked dosage forms of bitter tasting anti-retroviral drugs |
11/07/2012 | EP2519262A2 Antibody formulation |
11/07/2012 | EP2519261A1 Oral liquid pharmaceutical composition of nifedipine |
11/07/2012 | EP2519240A2 Pharmaceutical composition comprising metformin and rosuvastatin |
11/07/2012 | EP2519238A1 Beta-carbolines for use in the treatment of hearing loss and vertigo |
11/07/2012 | EP2519237A1 Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction |
11/07/2012 | EP2519232A1 Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones |
11/07/2012 | EP2519230A2 Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
11/07/2012 | EP2519229A2 New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
11/07/2012 | EP2519228A2 Polymeric conjugates of aromatic amine containing compounds including releasable urea linker |
11/07/2012 | EP2519227A2 Management of myoclonus with oral liposomal reduced glutathione |
11/07/2012 | EP2519226A1 Orally administrable film dosage forms containing ondansetron |
11/07/2012 | EP2519225A1 Melt extruded nicotine thin strips |
11/07/2012 | EP2519224A1 Melt extruded thin strips containing coated pharmaceutical actives |
11/07/2012 | EP2519199A1 Systems and methods for anesthetizing ear tissue |
11/07/2012 | EP2519108A1 Compositions and method for treatment and prophylaxis of inflammatory bowel disease |
11/07/2012 | DE20321906U1 Pramipexol-Dosierform zur einmal täglichen Verabreichung Pramipexole dosage for once daily administration |
11/07/2012 | DE202012008604U1 Camouflagekapsel zur dosierten Verabreichung eines Arzneistoffs Camouflagekapsel for the dosed administration of a drug |
11/07/2012 | CN202516036U Drug carrier |
11/07/2012 | CN202516035U Ache plaster |
11/07/2012 | CN1988886B Heat sterilization of glucocorticosteroids |
11/07/2012 | CN1985827B Compound ciprofloxacin injection for animal and its preparing process |
11/07/2012 | CN1943585B Breviscapine proliposome powder preparation |
11/07/2012 | CN1839826B Oral formulation for twice-daily administration |
11/07/2012 | CN1744901B Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis |
11/07/2012 | CN1638743B Implantable drug delivery system |
11/07/2012 | CN102770158A Antibody formulation |
11/07/2012 | CN102770157A Formulations of antibody |
11/07/2012 | CN102770152A Mucosal delivery of peptides |
11/07/2012 | CN102770143A Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture |
11/07/2012 | CN102770138A Nicotine-containing soft gelatin pastilles |
11/07/2012 | CN102770136A Therapeutic agent (Y - 39983) for corneal endothelial dysfunction |
11/07/2012 | CN102770135A Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect |
11/07/2012 | CN102770130A Adhesive patch containing bisoprolol |
11/07/2012 | CN102770128A Method for preventing the crystallisation of pharmaceuticals in a polymer film |
11/07/2012 | CN102770127A Abuse-resistant formulations |
11/07/2012 | CN102770126A Apixaban formulations |
11/07/2012 | CN102770125A Calcipotriol monohydrate nanocrystals |
11/07/2012 | CN102770124A Formulation comprising 1 H - quinazoline - 2, 4 - dione ampa receptor antagonists, in the form of immediate release tablets and preparation thereof |
11/07/2012 | CN102770123A Highly permeating terbinafine formulation for treating onychomycosis |
11/07/2012 | CN102770121A Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue |
11/07/2012 | CN102770120A Compositions and methods for mild sedation, anxiolysis and analgesia in the procedural setting |
11/07/2012 | CN102766262A Preparation method for difunctional nanoparticle carrier and preparation method for difunctional nanoparticle preparation |
11/07/2012 | CN102766228A Preparation method and application of polymeric micelle with triple responsiveness |
11/07/2012 | CN102766220A Hydrophobic modified beta-1, 3-D-glucan and preparation method and applications thereof |
11/07/2012 | CN102766215A Polypeptide with function of synergic targeting treatment of nasopharyngeal carcinoma, nanoparticle carrying the polypeptide and application thereof |
11/07/2012 | CN102766066A Gel factor as well as preparation method and application thereof |
11/07/2012 | CN102764442A Method for preparing nano particles comprising protamine and genetic material |
11/07/2012 | CN102764424A Drug composition of thymopentin composed of five kinds of amino acids and preparation method thereof |
11/07/2012 | CN102764423A Polypeptide drug composition obtained through hydrolysis of animal livers and preparation method thereof |
11/07/2012 | CN102764422A Xialian Yiyou capsule for curing chronic gastritis |
11/07/2012 | CN102764421A Pressure ulcer ointment |
11/07/2012 | CN102764420A Traditional Chinese medicine for treating urolithiasis and preparation and taking method thereof |
11/07/2012 | CN102764418A Medicine for treating anaudia and aphasia caused by apoplexy |
11/07/2012 | CN102764415A Oral liquid for preventing and treating various pains |
11/07/2012 | CN102764414A Method for preparing Xiaoqinglong mixture |
11/07/2012 | CN102764413A Di Zhen granule and preparation method thereof |